Markets:

Overview

News

Currencies

International

Treasuries

Codiak BioSciences, Inc. - Common Stock (NQ:CDAK)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 4, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Codiak BioSciences, Inc. - Common Stock

< Previous 1 2 Next >

Snap To $29, Plus Goldman Sachs Slashes PT On This Stock By 67% ↗

September 01, 2022

Credit Suisse cut the price target for Snap Inc. (NYSE: SNAP) from $35 to $29. Snap shares fell 0.5% to $10.83 in pre-market trading.

Via Benzinga

This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday ↗

August 19, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.

Via Benzinga

Codiak BioSciences' Engineered Exosome Candidates Show Early Antitumor Activity ↗

June 30, 2022

Via Benzinga

Codiak BioSciences's Pan Beta-Coronavirus Vaccine Shows Encouraging Action In Animal Studies ↗

April 21, 2022

Via Benzinga

Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

August 18, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

August 18, 2022

It's time to take a look at the biggest pre-market stock movers for Thursday and the news that's got those shares moving!

Via InvestorPlace

This Healthcare Stock Is Trading Lower By 29%: Here Are 29 Stocks Moving Premarket ↗

August 18, 2022

Gainers

Via Benzinga

The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study ↗

July 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Daily Biotech Pulse: Ampio Falls On Knee Osteoarthritis Trial Update, AstraZeneca's COVID-19 Antibody Data, CureVac-GSK's Bivalent COVID-19 Vaccine Data ↗

April 21, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday ↗

July 01, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...

Via Benzinga

Codiak BioSciences' Precision Medicine Approach Shows Potent Activity In Cancer Models ↗

April 11, 2022

Codiak BioSciences Inc (NASDAQ: CDAK)

Via Benzinga

Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session ↗

June 30, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical...

Via Benzinga

Codiak's COVID-19 Vaccine Hopeful Shows Potential In Preclinical Study ↗

December 02, 2021

Codiak BioSciences Inc (NASDAQ: CDAK) announced new preclinical data from its exoVACC exosome-based vaccine platform. The data showed that the COVID-19 vaccine...

Via Benzinga

91 Biggest Movers From Friday ↗

June 13, 2022

Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.

Via Benzinga

79 Biggest Movers From Yesterday ↗

June 08, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it...

Via Benzinga

Codiak BioSciences' Exosome Candidate Shows Tumor Shrinkage In Early Study ↗

November 16, 2021

Codiak BioSciences Inc (NASDAQ: CDAK) announced initial data for exoSTING currently in a Phase 1/2 trial as a single agent for the treatment of multiple solid...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

June 03, 2022

During Friday's trading, 69 companies set new 52-week lows.

Via Benzinga

Sarepta, Codiak Nix Exosome Therapy Development Pact ↗

October 08, 2021

Sarepta Therapeutics Inc (NASDAQ: SRPT) notified Codiak BioSciences Inc (NASDAQ: CDAK) that it would terminate the two-year Research License and Option...

Via Benzinga

44 Biggest Movers From Yesterday ↗

April 23, 2021

Gainers KnowBe4, Inc. (NASDAQ: KNBE) shares jumped 50.9% to close at $24.14 on Thursday after the company priced its IPO at $16 per share. Neuropace, Inc. (NASDAQ: NPCE) shares...

Via Benzinga

Topics Initial Public Offering

Stocks That Hit 52-Week Lows On Thursday ↗

June 02, 2022

During the Thursday's session, 100 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

April 20, 2022

On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...

Via Benzinga

65 Biggest Movers From Yesterday ↗

January 19, 2022

Gainers Brickell Biotech, Inc. (NASDAQ: BBI) shares jumped 58.6% to settle at $0.33 on Tuesday after HC Wainwright & Co initiated coverage on the stock with a Buy rating and...

Via Benzinga

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs ↗

October 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

84 Biggest Movers From Friday ↗

August 09, 2021

Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 41.3% to close at $4.86 on Friday after the company inked an agreement with turnkey mining solutions provider Hertford...

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Codiak BioSciences, Inc. - Common Stock (NQ:CDAK)

All News about Codiak BioSciences, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today